Clene Inc. financial data

Symbol
CLNN, CLNNW on Nasdaq
Industry
Pharmaceutical Preparations
Location
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah
Fiscal year end
December 31
Former names
Chelsea Worldwide Inc. (to 12/18/2020)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 236 % -2.05%
Quick Ratio 0.32 % -48.4%
Debt-to-equity 272 %
Return On Equity -322 % -124%
Return On Assets -86.5 % -25.9%
Operating Margin -6.3K % +24.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares +66.9%
Common Stock, Shares, Outstanding 128M shares +64.7%
Entity Public Float 78.1M USD -8.44%
Common Stock, Value, Issued 13K USD +62.5%
Weighted Average Number of Shares Outstanding, Basic 128M shares +68.9%
Weighted Average Number of Shares Outstanding, Diluted 63.5M shares -9.32%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 620K USD +12.7%
Cost of Revenue 132K USD +326%
Research and Development Expense 25.1M USD -18.2%
General and Administrative Expense 14.4M USD -7.63%
Costs and Expenses 39.7M USD -14.4%
Operating Income (Loss) -39M USD +14.8%
Nonoperating Income (Expense) -9.77M USD -156%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -48.8M USD -72.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -48.8M USD -72.3%
Earnings Per Share, Basic -0.41 USD/shares -2.5%
Earnings Per Share, Diluted -0.17 USD/shares -140%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 21.7M USD +17.8%
Marketable Securities, Current 6.18M USD
Cash, Cash Equivalents, and Short-term Investments 27.9M USD +51.6%
Accounts Receivable, after Allowance for Credit Loss, Current 64K USD +1.59%
Inventory, Net 37K USD -58%
Other Assets, Current 832K USD -13.5%
Assets, Current 32.1M USD +29.4%
Property, Plant and Equipment, Net 9.75M USD +130%
Operating Lease, Right-of-Use Asset 4.05M USD -9.97%
Assets 45.1M USD +13%
Accounts Payable, Current 1.65M USD +171%
Accrued Liabilities, Current 3.91M USD -34.2%
Liabilities, Current 26.2M USD +55.2%
Operating Lease, Liability, Noncurrent 4.72M USD -12.6%
Liabilities 40.8M USD -1.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax 140K USD -36.7%
Retained Earnings (Accumulated Deficit) -254M USD -23.8%
Stockholders' Equity Attributable to Parent 4.26M USD
Liabilities and Equity 45.1M USD +13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.08M USD +23.2%
Net Cash Provided by (Used in) Financing Activities -19K USD -100%
Net Cash Provided by (Used in) Investing Activities 71K USD -98.5%
Common Stock, Shares Authorized 300M shares +100%
Common Stock, Shares, Issued 128M shares +64.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.09M USD -6545%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 21.8M USD +17.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 784K USD -20.2%
Deferred Tax Assets, Valuation Allowance 57.3M USD +28.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 5.32M USD -9.95%
Depreciation 1.72M USD +40.5%
Payments to Acquire Property, Plant, and Equipment 11K USD -96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.9M USD -72.5%
Lessee, Operating Lease, Liability, to be Paid 7.15M USD -13.7%
Property, Plant and Equipment, Gross 14.7M USD +76.6%
Operating Lease, Liability, Current 599K USD +17.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.24M USD +2.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.21M USD +3.16%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.83M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD -8.04%
Deferred Tax Assets, Operating Loss Carryforwards 35.2M USD +15.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.09M USD -3.19%
Operating Lease, Payments 307K USD +1.32%
Additional Paid in Capital 258M USD +27%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Share-based Payment Arrangement, Expense 8.91M USD +4.37%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 4.74M USD +32.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%